It is tempting to speculate that circulating lymphocytes are entrapped by CD54-expressing tumour neovessels and become exposed to inhibitory cytokines (e.g. IL-10) and other bioactive substances originating in the tumour site (Mantovani et al, 2004). The gene discussed is ICAM1; the disease is neoplasm.